Cite
Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations.
MLA
Meyer, Larissa A., et al. “Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations.” Obstetrics & Gynecology, vol. 115, no. 5, May 2010, pp. 945–52. EBSCOhost, https://doi.org/10.1097/AOG.0b013e3181da08d7.
APA
Meyer, L. A., Anderson, M. E., Lacour, R. A., Suri, A., Daniels, M. S., Urbauer, D. L., Nogueras-Gonzalez, G. M., Schmeler, K. M., Gershenson, D. M., & Lu, K. H. (2010). Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations. Obstetrics & Gynecology, 115(5), 945–952. https://doi.org/10.1097/AOG.0b013e3181da08d7
Chicago
Meyer, Larissa A., Meaghan E. Anderson, Robin A. Lacour, Anuj Suri, Molly S. Daniels, Diana L. Urbauer, Graciela M. Nogueras-Gonzalez, Kathleen M. Schmeler, David M. Gershenson, and Karen H. Lu. 2010. “Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations.” Obstetrics & Gynecology 115 (5): 945–52. doi:10.1097/AOG.0b013e3181da08d7.